Immunodeficiency Clinical Trials in Baltimore, Maryland
5 recruitingBaltimore, Maryland
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Multiple MyelomaSecondary Immunodeficiency
Takeda183 enrolled24 locationsNCT06980480
Recruiting
Phase 2
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
LeiomyosarcomaSolid Organ Transplant ComplicationsLymphoproliferative Disorders+8 more
Pierre Fabre Medicament190 enrolled40 locationsNCT04554914
Recruiting
Not Applicable
Strategies to AchieVe Viral Suppression for Youth With HIV
Human Immunodeficiency Virus (HIV) Infection
Johns Hopkins University288 enrolled1 locationNCT06886971
Recruiting
Phase 1
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Viral InfectionHematopoietic Stem Cell Transplantation (HSCT)Primary Immunodeficiency Disorders (PID)
Children's National Research Institute48 enrolled3 locationsNCT04691622
Recruiting
Phase 4
An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)
Primary Immunodeficiency
CSL Behring8 enrolled8 locationsNCT07076446